Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer - Authors' reply

Bjørn H Grønberg, Seppo Wang Langer, Jan Nyman, Tarje Onsøien Halvorsen

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Adgang til dokumentet

@article{08b44724bd64484fa62ee9aa7bd027b9,

title = "Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer - Authors' reply",

author = "Gr{\o}nberg, {Bj{\o}rn H} and Langer, {Seppo Wang} and Jan Nyman and Halvorsen, {Tarje Ons{\o}ien}",

year = "2021",

month = jun,

doi = "10.1016/S1470-2045(21)00291-6",

language = "English",

volume = "22",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "TheLancet Publishing Group",

number = "6",

}

TY - JOUR

T1 - Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer - Authors' reply

AU - Grønberg, Bjørn H

AU - Langer, Seppo Wang

AU - Nyman, Jan

AU - Halvorsen, Tarje Onsøien

PY - 2021/6

Y1 - 2021/6

U2 - 10.1016/S1470-2045(21)00291-6

DO - 10.1016/S1470-2045(21)00291-6

M3 - Comment/debate

C2 - 34087132

VL - 22

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 6

M1 - e222

ER -